JPH07509243A - 架橋陽イオン重合体とアルコキシ化エーテルとを含有する局所用途用医薬組成物 - Google Patents
架橋陽イオン重合体とアルコキシ化エーテルとを含有する局所用途用医薬組成物Info
- Publication number
- JPH07509243A JPH07509243A JP6504516A JP50451694A JPH07509243A JP H07509243 A JPH07509243 A JP H07509243A JP 6504516 A JP6504516 A JP 6504516A JP 50451694 A JP50451694 A JP 50451694A JP H07509243 A JPH07509243 A JP H07509243A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- mixtures
- hydrochloride
- group
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (19)
- 1.(a)安全で有効な量の医薬有効成分;(b)式(A)1(B)m(C)n (式中、(A)はジアルキルアミノアルキルァクリレート単量体またはその第四 級アンモニウムまたは酸付加塩であり、(B)はジアルキルアミノアルキルメタ クリレート単量体またはその第四級アンモニウムまたは酸付加塩であり、(C) はアクリルアミドであり、1は0以上の整数であり、mは1以上の整数であり、 nは0以上の整数である)の高分子量架橋陽イオン重合体(該重合体は架橋剤を 含有する)0.1%〜10.0%;(c)高HLB非イオン界面活性剤0.05 %〜5%;および (d)式 ▲数式、化学式、表等があります▼ (式中、Rは直鎖または分枝鎖C1〜C18であり、Xはメチルまたはエチルで あり、nは5〜20の平均値を有する) のアルコキシ化エーテル0.1%〜25%を含むことを特徴とする皮膚を通して 高められた浸透を有する局所医薬組成物。
- 2.架橋剤がメチレンビスァクリルアミド、エチレングリコールジ−(メタ)ア クリレート、ジ−(メタ)アクリルアミド、シアノメチルアクリレート、ビニル オキシエチルアクリレート、ビニルオキシエチルメタクリレート、アリルペンタ エリトリトール、トリメチロールプロパンジアリルウーテル、アリルスクロース 、ブタジエン、イソプレン、ジビニルベンゼン、ジビニルナフタレン、アリルア クリレート、およびそれらの混合物からなる群から選ばれ、好ましくはメチレン ビスアクリルアミドである、請求項1に記載の組成物。
- 3.上記高HLB非イオン界面活性剤が8〜22個の炭素および6〜30個のエ チレンオキシド基を有するエトキシ化アルコールから選ばれ、好ましくは上記高 HLB非イオン界面活性剤がセテトー10、ステアレトー21、およびそれらの 混合物からなる群から選ばれ、且つ上記アルコキシ化エーテルがPPG−14ブ チルエーテル、PPG−15ステアリルエーテル、およびそれらの混合物からな る群から選ばれる、請求項2に記載の組成物。
- 4.上記医薬有効成分が抗座瘡薬、しわ防止有効成分、皮膚萎縮防止有効成分、 非ステロイド抗炎症薬、ステロイド抗炎症薬、サンレス日焼け剤、日焼け止め剤 、創傷治癒剤、皮膚漂白または淡色化剤、抗ヒスタミン薬、鎮咳薬、止痒薬、抗 コリン作用薬、抗嘔吐および制吐薬、食欲減退薬、中枢興奮薬、抗不整脈薬、β −アドレナリン遮断薬、強心葉、抗高血圧薬、利尿薬、血管拡張薬、血管収縮薬 、仇潰瘍薬、麻酔薬、抗うっ薬、精神安定薬および鎮静薬、抗精神病薬、抗菌薬 、抗腫瘍薬、抗マラリア薬、筋弛緩薬、鎮痙薬、止しゃ薬および骨活性薬および それらの混合物からなる群から選はれ;好ましくは上記抗ヒスタミン薬がマレイ ン酸クロルフェニラミン、タンニン酸クロルフェニラミン、塩酸トリプロリジン 、シュウ酸トリプロリジン、塩酸ジフェンヒドラミン、アスコルビン酸ジフェン ヒドラミン、クエン酸ジフェンヒドラミン、コハク酸ドキシラミン、マレイン酸 ピリラミン、塩酸ピリラミン、タンニン酸ピリラミン、酒石酸フェニンダミン、 塩酸プロメタジン、塩酸シプロヘプタジン、マレイン酸アザタジン、フマル酸ク レマスチン、マレイン酸カルビノキサミン、塩酸カルビノキサミン、塩酸トリペ レナミン、クエン酸トリペレナミン、マレイン酸d−ロルフェニラミン、マレイ ン酸ブロムフエニルアミンおよび塩酸クロルサイクリジンおよびそれらの混合物 からなる群から選ばれ;上記鎮咳薬が臭化水素酸デキストロメトルファン、クエ ン酸カルベタペンタン、リン酸コデインおよび塩酸コデインN−オキシドおよび それらの混合物からなる群から選ばれ;上記抗コリン作用薬が臭化水素酸スコポ ラミン、塩酸スコポラミン、確酸アトロピン、粘液酸アトロピン、臭化水素酸ホ マトロピンおよび塩酸ホマトロピンおよびそれらの混合物からなる群から選ばれ ;上記抗嘔吐または制吐薬が塩酸シクリジン、塩酸メクリジン、塩酸クロルプロ マジンおよびマレイン酸クロルプロマジンおよびそれらの混合物からなる群から 選ばれ;上記食欲減退薬が塩酸ベンズフェタミン、塩酸フェンテルミン、塩酸ク ロルフェンテルミンおよび塩酸フェンフルラミンおよびそれらの混合物からなる 群から選ばれ;上記抗菌薬がβ−ラクタム薬、キノロン薬、シプロフロキサシン 、ノルフロキサシン、テトラサイクリン、エリスロマイシン、イセチオン酸ヘキ サミジン、アミカシン、トリクロサン、ドキシサイクリン、カプレオマイシン、 クロルヘキシジン、クロルテトラサイクリン、オキシテトラサイクリン、クリン ダマイシン、エタンブトール、メトロニダゾル、ペンタミジン、ゲンタマイシン 、カナマイシン、リネオマイシン、メタサイタリン、メテナミン、ミノサイタリ ン、ネオマイシン、ネチルマイシン、パロモマイシン、ストレプトマイシン、ト ブラマイシン、ミコナゾールおよびアマソファジン、それらの製薬上許容可能な 塩およびそれらの混合物からなる群から選ばれ;上記抗不整脈薬が塩酸プロプラ ノロール、塩酸プロカインアミド、硫酸キニジン、グルコン酸キニジンおよびそ れらの混合物からなる群から選ばれ;上記抗高血圧薬がマレイン酸エナルアプリ ル、塩酸クロニジン、塩酸ヒドララジンおよび硫酸ヒドララジンおよびそれらの 混合物からなる群から選はれ;上記麻酔薬または止痒薬が塩酸リドカイン、塩酸 ブピバカイン、塩酸クロルプロカイン、塩酸ジブカイン、塩酸エチドカイン、塩 酸メピバカイン、塩酸テトラカイン、塩酸ジクロニンおよび塩酸ヘキシルカイン およびそれらの混合物からなる群から選ばれ;上記骨活性薬が6−アミノ−1− ヒドロキシヘキサン−1,1−ジホスホン酸、3−アミン−1−ヒドロキシ−プ ロパン−1,1−ジホスホン酸、オクタヒドロ−1−ピリジン−6,6−ジホス ホン酸、2−(2′−ピペリジニル)エタン−1,1−ジホスホン酸、2−(3 ′−ピペリジニル)エタン−1,1−ジホスホン酸、2−(2′一ピペリジニル )−1−ヒドロキシーエタン−1,1−ジホスホン酸、2−(3′−ピペリジニ ル)−1−ヒドロキシ−エタン−1,1−ジホスホン酸、N−(2′−(3′− メチル)−ピペリジニリデン)−アミノメタンジホスホン酸、N−(2′−(1 ′,3′−ジアジニリデン))−アミノメタンジホスホン酸、およびN−(2− (3−メチル−ピペリジニリデン))−アミノメタンホスホノメチルホスフィン 酸、またはそれらのエステルおよびそれらの混合物からなる群から選ばれ;上記 非ステロイド抗炎症薬がプロピオン酸誘導体、酢酸誘導体、フェナミン酸誘導体 、ビフェニルカルボン酸誘導体、およびオキシカムおよびそれらの混合物からな る群から選ばれ;上記非ステロイド抗炎症薬がアスピリン、アセトアミノフェン 、イブプロフェン、ナプロキセン、ベノキサプロフェン、フルルビプロフエン、 フェノプロフェン、フェンブフェン、ケトプロフェン、インドプロフェン、ピル プロフェン、カルプロフェン、オキサプロジン、プラノプロフェン、ミロプロフ ェン、チオキサプロフェン、スプロフェン、アルミノプロフェン、チアプロフェ ン酸、フルプロフェンおよびブクロキシン酸およびそれらの混合物からなる群か ら選ばれるプロピオン酸誘導体である、請求項3に記載の阻組成物。
- 5.上記医薬有効成分がサリチル酸、硫黄、レゾルシノール、N−アセチルシス テイン、オクトピロックス、レチン酸およびその誘導体、過酸化ベンゾイル、エ リスロマイシン、亜鉛、テトラサイクリン、アゼライン酸およびその誘導体、フ ェノキシエタノールおよびフェノキシプロパノール、酢酸エチル、クリンダマイ シンおよびメクロサイクリン、フラビノイド、乳酸、グリコール酸、ピルビン酸 、尿素、硫酸シムノールおよびその誘導体、デオキシコレートおよびコレートお よびそれらの混合物からなる群から選ばれる抗癌瘡桑、またはグリコール酸、乳 酸、サリチル酸、およびそれらの混合物からなる群がら選ばれるしわ防止有効成 分または皮膚萎縮防止有効成分である、請求項3に記載の組成物。
- 6.上記医薬有効成分がサリチル酸、グリコール酸、乳酸、およびそれらの混合 物からなる群から選ばれる、請求項3に記載の組成物。
- 7.陽イオン重合体中の(C)の量が50〜90モル%であり;好ましくは陽イ オン重合体中の1が0であり且つ(B):(C)の比率が45:55から55: 45であり;より好ましくは1とnとの両方とも陽イオン重合体中で0である、 請求項5に記載の組成物。
- 8.グリセリン3%〜5%、および揮発性シリコーン油、不揮発性シリコーン油 、高分枝炭化水素、およびそれらの混合物からなる群から選ばれるエモリエント 1%〜10%を更に含む、請求項7に記載の組成物。
- 9.上記薬物有効成分がジヒドロキシアセトン、インドール誘導体およびそれら の誘導体からなる群から選ばれるサンレス日焼け剤であり;好ましくは上記組成 物がp−メトキシケイ皮酸2−エチルヘキシル、N,N−ジメチル−p−アミノ 安息香酸2−エチルヘキシル、p−アミノ安息香酸、2−フェニルベンズイミダ ゾール−5−スルホン酸、オクトクリレン、オキシベンゾン、サリチル酸ホモメ ンチル、サリチル酸オクチル、4,4′−メトキシ−t−ブチルジベンゾイルメ タン、4−イソプロピルジベンゾイルメタン、3−ベンジリデンショウノウ、3 −(4−メチルベンジリデン)ショウノウ、二酸化チタン、酸化亜鉛、シリカ、 酸化鉄、およびそれらの混合物からなる群から選ばれる日焼け止め有効成分を更 に含む、請求項3に記載の組成物。
- 10. (a)安全で有効な量の医薬有効成分;(b)式(A)1(B)m(C)n(式 中、(A)はジアルキルアミノアルキルアクリレート単量体またはその第四級ア ンモニウムまたは酸付加塩であり、(B)はジアルキルアミノアルキルメタクリ レート単量体またはその第四級アンモニウムまたは酸付加塩であり、(C)はア クリルアミドであり、1は0以上の整数であり、mは1以上の整数であり、nは 0以上の整数である)の高分子量架橋陽イオン重合体(該重合体は架橋剤を含有 する)0.1%〜10.0%;(c)高HLB非イオン界面活性剤0.05%〜 5%;(d)低HLB非イオン界面活性剤0.01%〜5%;および (e)式 ▲数式、化学式、表等があります▼ (式中、Rは直鎖または分枝鎖C1〜C18であり、Xはメチルまたはエチルで あり、nは5〜20の平均値を有する) のアルコキシ化エーテル0.1%〜25%を含むことを特徴とする皮膚を通して 高められた浸透を有する局所医薬組成物。
- 11.架橋剤がメチレンビスァクリルアミド、エチレングリコールジ−(メタ) アクリレート、ジ−(メタ)アクリルアミド、シアノメチノレアクリレート、ビ ニルオキシエチルアクリレート、ビニルオキシエチルメタクリレート、アリルペ ンタエリトリトール、トリメチロールプロパンジアリルエーテル、アリルスクロ ース、ブタジエン、イソプレン、ジビニルペンゼン、ジビニルナフタレン、アリ ルアクリレート、およびそれらの混合物からなる群から選ばれ、好ましくは上記 架橋剤がメチレンビスアクリルアミドである、請求項10に記載の組成物。
- 12.上記高HLB非イオン界面活性剤が8〜22個の炭素および6〜30個の エチレンオキシド基を有するエトキシ化アルコールから選ばれ、好ましくは上記 高HLB非イオン界面活性剤がセテトー10、ステアレトー21、およびそれら の混合物からなる群から選ばれ、員つ上記アルコキシ化エーテルがPPG−14 ブチルエーテル、PPG−15ステアリルエーテル、およびそれらの混合物から なる群から選ばれる、請求項11に記載の組成物。
- 13.上記低HLB非イオン界面活性剤が8〜22個の炭素および1〜5個のエ チレンオキシド基を有するエトキシ化アルコールから選ばれ、好ましくは上記低 HLB非イオン界面活性剤がステアレトー2、セチトー2、ラウレトー2、オレ トー2、およびそれらの混合物からなる群から選ばれ、且つより好ましくは上記 低HLB非イオン界面活性剤がステアレトー2である、請求項12に記載の組成 物。
- 14.上記医薬有効成分が抗座瘡薬、しわ防止有効成分、皮膚萎縮防止有効成分 、非ステロイド抗炎症薬、ステロイド抗炎症薬、サンレス日焼け剤、日焼け止め 剤、創傷治癒剤、皮膚漂白または淡色化剤、抗ヒスタミン薬、鎮咳薬、止痒薬、 抗コリン作用薬、抗嘔吐および制吐薬、食欲減退薬、中枢興奮薬、抗不整脈薬、 β−アドレナリン遮断薬、強心薬、抗高血圧薬、利尿薬、血管拡張薬、血管収縮 薬、抗潰癌薬、麻酔薬、抗うつ薬、精神安定薬および鎮静薬、抗精神病薬、抗菌 薬、抗腫瘍薬、抗マラリア薬、筋弛緩薬、鎮痙薬、止しゃ薬および骨活性薬およ びそれらの混合物からなる群から選ばれる、請求項13に記載の組成物。
- 15.上記医薬有効成分がサリチル酸、硫黄、レゾルシノール、N−アセチルシ ステイン、オクトピロックス、レチン酸およびその誘導体、過酸化ベンゾイル、 エリスロマイシン、亜鉛、テトラサイクリン、アゼライン酸およびその誘導体、 フェノキシエタノールおよびフェノキシプロパノール、酢酸エチル、クリンダマ イシンおよびメクロサイクリン、フラビノイド、乳酸、グリコール酸、ピルビン 酸、尿素、硫酸シムノールおよびその誘導体、デオキシコレートおよびコレート およびそれらの混合物からなる群から選ばれる抗座瘡案、またはグリコール酸、 乳酸、サリチル酸、およびそれらの混合物からなる群から選ばれるしわ防止有効 成分または皮膚萎縮防止有効成分である、請求項13に記載の組成物。
- 16.上記医薬有効成分がサリチル酸、乳酸、グリコール酸、およびそれらの混 合物からなる群から選ばれる、請求項13に記載の組成物。
- 17.陽イオン重合体中の(C)の量が50〜90モル%であり;好ましくは陽 イオン重合体中の1が0であり且つ(B):(C)の比率が45:55から55 :45であり;より好ましくは1とnとの両方とも陽イオン重合体中で0である 、請求項13に記載の組成物。
- 18.グリセリン3%〜5%、および揮発性シリコーン油、不揮発性シリコーン 油、高分枝炭化水素、およびそれらの混合物からなる群から選ばれるエモリエン ト1%〜10%を更に含む、請求項17に記載の組成物。
- 19.上記薬物有効成分がジヒドロキシアセトン、インドール誘導体およびそれ らの誘導体からなる群から選ばれるサンレス日焼け剤であり;好ましくは上記組 成物がp−メトキシケイ皮酸2−エチルヘキシル、N,N−ジメチル−P−アミ ノ安息香酸2−エチルヘキシル、p−アミノ安息香酸、2−フェニルベンズイミ ダゾール−5−スルホン酸、オクトクリレン、オキシベンゾン、サリチル酸ホモ メンチル、サリチル酸オクチル、4,4′−メトキシ−t−ブチルジベンゾイル メタン、4−イソプロピルジベンゾイルメタン、3−ベンジリデンショウノウ、 3−(4−メチルベンジリデン)シヨウノウ、二酸化チタン、酸化亜鉛、シリカ 、酸化鉄、およびそれらの混合物からなる群から選ばれる日焼け止め有効成分を 更に含む、請求項13に記載の組成物。
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92093792A | 1992-07-28 | 1992-07-28 | |
US920,937 | 1992-07-28 | ||
US95052792A | 1992-09-25 | 1992-09-25 | |
US950,527 | 1992-09-25 | ||
US3321193A | 1993-03-18 | 1993-03-18 | |
US033,211 | 1993-03-18 | ||
US7997793A | 1993-06-25 | 1993-06-25 | |
US079,977 | 1993-06-25 | ||
PCT/US1993/006542 WO1994002176A1 (en) | 1992-07-28 | 1993-07-12 | Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07509243A true JPH07509243A (ja) | 1995-10-12 |
JP3567990B2 JP3567990B2 (ja) | 2004-09-22 |
Family
ID=27488097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50451694A Expired - Lifetime JP3567990B2 (ja) | 1992-07-28 | 1993-07-12 | 架橋陽イオン重合体とアルコキシ化エーテルとを含有する局所用途用医薬組成物 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5614178A (ja) |
EP (1) | EP0652774B1 (ja) |
JP (1) | JP3567990B2 (ja) |
KR (1) | KR950702436A (ja) |
CN (1) | CN1072965C (ja) |
AT (1) | ATE152630T1 (ja) |
AU (1) | AU4673993A (ja) |
BR (1) | BR9306816A (ja) |
CA (1) | CA2141192C (ja) |
DE (1) | DE69310518T2 (ja) |
ES (1) | ES2101330T3 (ja) |
FI (1) | FI950368A (ja) |
HK (1) | HK1006281A1 (ja) |
MX (1) | MX9304530A (ja) |
NO (1) | NO950291L (ja) |
WO (1) | WO1994002176A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08508024A (ja) * | 1993-03-16 | 1996-08-27 | ロレアル | 非揮発性オルガノポリシロキサンと、ホモポリマータイプまたはアクリルアミドとのコポリマーのタイプのメタクリロイルオキシエチルトリメチルアンモニウムクロライドの架橋ポリマーとを基体とする水性分散液の香粧品中での使用または局所的適用 |
JP2011512377A (ja) * | 2008-02-19 | 2011-04-21 | ユニリーバー・ナームローゼ・ベンノートシヤープ | カチオン性コポリマーとデンプンとを配合したソフトフォーカスな輝きを与える化粧用組成物 |
JP2011512375A (ja) * | 2008-02-19 | 2011-04-21 | ユニリーバー・ナームローゼ・ベンノートシヤープ | カチオン性コポリマーによる光沢および非日光性日焼け色の強化 |
Families Citing this family (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2114569T3 (es) * | 1991-10-16 | 1998-06-01 | Richardson Vicks Inc | Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos. |
CA2168543A1 (en) * | 1993-07-03 | 1995-02-09 | George Endel Deckner | Personal cleansing compositions |
US5989536A (en) * | 1993-07-03 | 1999-11-23 | The Procter & Gamble Company | Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin |
DE69519372T3 (de) † | 1994-02-18 | 2004-06-09 | Unilever Plc | Hautreinigungsmittel |
CN1145582A (zh) * | 1994-03-11 | 1997-03-19 | 普罗克特和甘保尔公司 | 含有酸性活性物质的低pH值的水解稳定的化妆品组合物 |
US20020048596A1 (en) * | 1994-12-30 | 2002-04-25 | Gregor Cevc | Preparation for the transport of an active substance across barriers |
US5948416A (en) * | 1995-06-29 | 1999-09-07 | The Procter & Gamble Company | Stable topical compositions |
DE19603018C2 (de) * | 1996-01-17 | 1998-02-26 | Lancaster Group Gmbh | Kosmetisches Selbstbräunungsmittel mit Lichtschutzwirkung |
US5759524A (en) * | 1996-02-09 | 1998-06-02 | The Procter & Gamble Company | Photoprotective compositions |
US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
US6093408A (en) * | 1996-10-25 | 2000-07-25 | The Procter & Gamble Company | Skin care compositions |
US5916543A (en) * | 1996-12-18 | 1999-06-29 | Schering-Plough Healthcare Products, Inc. | Emulsions having minimal rub-in times |
US5951989A (en) * | 1997-04-07 | 1999-09-14 | Heymann; Warren R. | Method for the treatment of dry skin |
CA2232855C (en) | 1997-04-10 | 2007-10-09 | Roche Consumer Health (Worldwide) Sa | Pharmaceutical formulation |
US20050058709A1 (en) * | 1997-06-04 | 2005-03-17 | Fisher Gary J. | Methods for inhibiting photoaging of human skin using orally-administered agent |
TWI234467B (en) * | 1997-06-04 | 2005-06-21 | Univ Michigan | Composition for inhibiting photoaging of skin |
EP0884045A1 (en) | 1997-06-06 | 1998-12-16 | Pfizer Products Inc. | Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery |
US6210705B1 (en) | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
KR20010041852A (ko) | 1998-03-12 | 2001-05-25 | 데이비드 엠 모이어 | 효소 저해제를 함유하는 스킨 케어 조성물을 갖는 일회용흡수제품 |
CN1192766C (zh) * | 1998-10-23 | 2005-03-16 | 伊迪亚股份公司 | 开发、测试和使用用于改进的有效负载和可控制性解缔/缔合速度的大分子和复合聚集体的缔合物的方法 |
FR2785803B1 (fr) * | 1998-11-17 | 2005-03-25 | Sanofi Sa | Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes |
PT1031347E (pt) | 1999-01-27 | 2002-09-30 | Idea Ag | Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis |
ATE216875T1 (de) | 1999-01-27 | 2002-05-15 | Idea Ag | Nichtinvasive impfung durch die haut |
US6262117B1 (en) | 1999-02-18 | 2001-07-17 | Allergan Sales, Inc. | Method and composition for treating acne |
US20050191337A1 (en) * | 1999-03-31 | 2005-09-01 | L'oreal S.A. | Patch with a magnetic field effect |
US6444647B1 (en) | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
US6368618B1 (en) * | 1999-07-01 | 2002-04-09 | The University Of Georgia Research Foundation, Inc. | Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
WO2001001962A1 (en) * | 1999-07-05 | 2001-01-11 | Idea Ag. | A method for the improvement of transport across adaptable semi-permeable barriers |
US6849252B1 (en) * | 1999-09-03 | 2005-02-01 | The Procter & Gamble Company | Hair care composition comprising a polypropylene glycol |
JP2003516955A (ja) * | 1999-12-17 | 2003-05-20 | ザ、プロクター、エンド、ギャンブル、カンパニー | 活性成分の有効な放出のための組成物 |
JP4653282B2 (ja) * | 2000-05-23 | 2011-03-16 | 昭和薬品化工株式会社 | ミノサイクリン含有組成物 |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
GB0029198D0 (en) * | 2000-11-30 | 2001-01-17 | Ciba Sc Holding Ag | Liquid dispersion polymer compositions their preparation and their use |
US6869618B2 (en) | 2001-04-10 | 2005-03-22 | Kiel Laboratories, Inc. | Process for preparing tannate liquid and semi-solid dosage forms |
US7273623B2 (en) | 2001-10-12 | 2007-09-25 | Kiel Laboratories, Inc. | Process for preparing tannate tablet, capsule or other solid dosage forms |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
RU2286801C2 (ru) * | 2001-05-01 | 2006-11-10 | Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук | Двухфазные биоадгезионные композиции, абсорбирующие воду |
US8728445B2 (en) | 2001-05-01 | 2014-05-20 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel Compositions |
US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US8541021B2 (en) * | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
CA2446060A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
US6486199B1 (en) | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
US20030060422A1 (en) | 2001-08-31 | 2003-03-27 | Balaji Venkataraman | Tannate compositions and methods of treatment |
US6509492B1 (en) | 2001-08-31 | 2003-01-21 | First Horizon Pharmaceutical Corporation | Tannate compositions and methods of treatment |
US6830746B2 (en) * | 2001-09-21 | 2004-12-14 | Playtex Products, Inc. | Sunscreen compositions |
AU2003217704A1 (en) * | 2002-04-09 | 2003-10-27 | Kiel Laboratories, Inc | Diphenhydramine tannate compositions and methods of use |
US20030204180A1 (en) * | 2002-04-30 | 2003-10-30 | Kimberly-Clark Worldwide, Inc. | Temperature responsive delivery systems |
US20030232094A1 (en) * | 2002-06-12 | 2003-12-18 | Fuller Peter E. | Composition and method for the treatment of skin irritations |
US20080125441A1 (en) * | 2002-06-21 | 2008-05-29 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
US7371778B2 (en) | 2002-06-21 | 2008-05-13 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
US6906205B2 (en) * | 2002-06-21 | 2005-06-14 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
US7473432B2 (en) * | 2002-10-11 | 2009-01-06 | Idea Ag | NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9211259B2 (en) * | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
MXPA05004278A (es) | 2002-10-25 | 2005-10-05 | Foamix Ltd | Espuma cosmetica y farmaceutica. |
US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US7939489B2 (en) * | 2002-12-23 | 2011-05-10 | Avon Products, Inc. | Oil absorbent topical compositions and methods for using same |
US20040175347A1 (en) * | 2003-03-04 | 2004-09-09 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using hexamidine compositions |
US20080076720A1 (en) * | 2003-03-04 | 2008-03-27 | Sancai Xie | Personal care compositions having kinetin or zeatin |
US20060074097A1 (en) * | 2003-03-04 | 2006-04-06 | Bissett Donald L | Regulation of mammalian keratinous tissue using hexamidine compositions |
WO2004093867A2 (en) * | 2003-03-25 | 2004-11-04 | Kiel Laboratories, Inc. | Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use |
WO2004093866A1 (en) * | 2003-03-25 | 2004-11-04 | Kiel Laboratories, Inc. | Process for preparing phenolic acid salts of gabapentin |
EP1622603A4 (en) * | 2003-03-25 | 2010-03-24 | Kiel Lab Inc | GABAPENTINIC PHENOLIC ACID SALTS IN SOLID DOSAGE FORMS AND METHODS OF USE |
US7285570B2 (en) * | 2003-04-17 | 2007-10-23 | The Procter & Gamble Company | Compositions and methods for regulating mammalian keratinous tissue |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
WO2004108092A2 (en) * | 2003-06-05 | 2004-12-16 | P3 Laboratories, Inc. | Tannate compositions and methods of use |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US20080069779A1 (en) * | 2003-08-04 | 2008-03-20 | Foamix Ltd. | Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
DE10338174A1 (de) * | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
US20050075407A1 (en) * | 2003-08-25 | 2005-04-07 | Foamix Ltd. | Foam incorporating eutetic mixture |
CN100411692C (zh) * | 2004-01-13 | 2008-08-20 | 北京康倍得医药技术开发有限公司 | 丙烯酸基粘合剂组合物及其药物组合物和透皮治疗系统 |
CA2554649C (en) | 2004-01-30 | 2015-10-27 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
AU2005201455A1 (en) * | 2004-02-04 | 2005-08-25 | Foamix Ltd. | Cosmetic and pharmaceutical foam with solid matter |
JP2005310310A (ja) * | 2004-04-23 | 2005-11-04 | Sanyo Electric Co Ltd | トラッキングバランス調整装置 |
GB0410860D0 (en) * | 2004-05-15 | 2004-06-16 | Boots Healthcare Int Ltd | Skincare composition |
EP1791575B1 (en) * | 2004-08-05 | 2014-10-08 | Corium International, Inc. | Adhesive composition |
US20060045858A1 (en) * | 2004-08-26 | 2006-03-02 | Fuller Peter E | Composition and method for reducing harmful effects of ultraviolet radiation impinging on the skin |
US7288263B2 (en) * | 2004-09-13 | 2007-10-30 | Evera Laboratories, Llc | Compositions and methods for treatment of skin discoloration |
KR20070086045A (ko) * | 2004-11-12 | 2007-08-27 | 이데아 아게 | 피부 상태 치료에서의 확대된 표면 집합체 |
PE20061303A1 (es) * | 2005-03-30 | 2006-12-07 | Astion Dev As | Composicion farmaceutica que comprende oxaprozina |
US8067620B2 (en) * | 2005-05-04 | 2011-11-29 | Medicines For Malaria Venture Mmv | Dispiro 1,2,4-trioxolane antimalarials |
US20070071705A1 (en) * | 2005-09-29 | 2007-03-29 | De Oliveira Monica A M | Topical anti-microbial compositions |
DE602005022132D1 (de) * | 2005-10-26 | 2010-08-12 | Kpss Kao Gmbh | Haarkonditioniermittel enthaltend Polyquaternium-37 |
US20070128137A1 (en) * | 2005-12-02 | 2007-06-07 | Naohisa Yoshimi | Water in oil emulsion compositions containing siloxane elastomers |
US20070274932A1 (en) * | 2006-05-15 | 2007-11-29 | The Procter & Gamble Company | Water in oil emulsion compositions containing sunscreen actives and siloxane elastomers |
EP2018148A2 (en) * | 2006-05-15 | 2009-01-28 | The Procter and Gamble Company | Method of enhancing penetration of water-soluble actives |
US20080038360A1 (en) * | 2006-08-11 | 2008-02-14 | Joseph Michael Zukowski | Personal care composition |
US20080260655A1 (en) * | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
FR2909279B1 (fr) * | 2006-11-30 | 2014-06-13 | Oreal | Procede de peeling a base de microgel cationique |
US20080292560A1 (en) * | 2007-01-12 | 2008-11-27 | Dov Tamarkin | Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent |
US20080188445A1 (en) * | 2007-02-02 | 2008-08-07 | Warner Chilcott Company Inc. | Tetracycline compositions for topical administration |
US20080188446A1 (en) * | 2007-02-02 | 2008-08-07 | Warner Chilcott Company Inc. | Tetracycline compositions for topical administration |
AR065378A1 (es) * | 2007-02-16 | 2009-06-03 | Procter & Gamble | Articulo absorbente con locion que comprende un material de polipropilenglicol |
EP1986473B1 (en) * | 2007-04-03 | 2017-01-25 | Tsinghua University | Organic electroluminescent device |
US20090011035A1 (en) * | 2007-07-03 | 2009-01-08 | Joseph Michael Zukowski | Personal care composition |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US8003621B2 (en) | 2007-09-14 | 2011-08-23 | Nitto Denko Corporation | Drug carriers |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
UY31531A1 (es) * | 2007-12-17 | 2009-08-03 | Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr) | |
AU2009205314A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
US8636988B2 (en) * | 2008-01-31 | 2014-01-28 | Doctor Essentials | Composition for treatment of sunburned skin |
US8784879B2 (en) | 2009-01-14 | 2014-07-22 | Corium International, Inc. | Transdermal administration of tamsulosin |
JP5788864B2 (ja) | 2009-04-03 | 2015-10-07 | セイント レナタス, エルエルシー | 鼻腔内投与用のテトラカインおよび血管収縮薬を含む歯科用麻酔剤 |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
TWI495465B (zh) * | 2009-09-30 | 2015-08-11 | Shiseido Co Ltd | A heparinase activity inhibitor and a wrinkle improving agent and a pharmaceutical composition containing the same |
CA2776366C (en) | 2009-10-02 | 2017-07-18 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
AU2012245274B2 (en) * | 2011-04-20 | 2016-09-22 | Kao Usa, Inc. | Self-tanning compositions having reduced Maillard reaction malodor |
SE1300709A1 (sv) * | 2013-11-14 | 2015-05-15 | Lipidor Ab | Komposition och metod för topikal behandling |
JP2014015426A (ja) * | 2012-07-10 | 2014-01-30 | Wacker Asahikasei Silicone Co Ltd | 入浴剤用シリコーンエマルジョン組成物 |
US9687455B2 (en) | 2014-08-14 | 2017-06-27 | John Daniel Dobak | Sodium tetradecyl sulfate formulations for treatment of adipose tissue |
US9351945B1 (en) | 2015-02-27 | 2016-05-31 | John Daniel Dobak, III | Reduction of adipose tissue |
MX2017011630A (es) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Composiciones y metodos para tratar rosacea y acne. |
JP2020534285A (ja) | 2017-09-15 | 2020-11-26 | アンパサンド バイオファーマシューティカルズ インコーポレイテッドAmpersand Biopharmaceuticals Inc. | 投与および処置の方法 |
CN108467464A (zh) * | 2018-04-02 | 2018-08-31 | 常熟理工学院 | 含壬二酸可见光固化水凝胶及其制备方法 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1243470A (en) * | 1969-01-31 | 1971-08-18 | Unilever Ltd | Hairdressings |
US4009256A (en) * | 1973-11-19 | 1977-02-22 | National Starch And Chemical Corporation | Novel shampoo composition containing a water-soluble cationic polymer |
US3920810A (en) * | 1974-04-23 | 1975-11-18 | Burton Parsons And Company Inc | Polyacrylamide containing ophthalmic solutions |
US4039501A (en) * | 1975-05-30 | 1977-08-02 | National Patent Development Corporation | Plasticized hydrophilic polymers |
US4355028A (en) * | 1978-04-04 | 1982-10-19 | Westwood Pharmaceuticals, Inc. | Composition for treating acne vulgaris |
US4318907A (en) * | 1978-04-04 | 1982-03-09 | Westwood Pharmaceuticals, Inc. | Method for treating acne vulgaris and compositions useful for that purpose |
JPS596287B2 (ja) * | 1980-11-28 | 1984-02-10 | 日東電工株式会社 | 医薬製剤 |
AU8409582A (en) * | 1981-06-15 | 1982-12-23 | Alcon Laboratories, Inc. | Urea and carboxyvinyl polymers gel compositions |
US4540568A (en) * | 1982-10-14 | 1985-09-10 | Trager Seymour F | Injectionable viscoelastic ophthalmic gel |
GB8401206D0 (en) * | 1984-01-17 | 1984-02-22 | Allied Colloids Ltd | Polymers and aqueous solutions |
GB8414950D0 (en) * | 1984-06-12 | 1984-07-18 | Allied Colloids Ltd | Cationic polyelectrolytes |
GB8416453D0 (en) * | 1984-06-28 | 1984-08-01 | Allied Colloids Ltd | Aqueous polymer dispersions |
US5017367A (en) * | 1984-10-01 | 1991-05-21 | Stojkoski Radmila G | Skin treatment preparation |
US4608370A (en) * | 1985-03-04 | 1986-08-26 | Aronsohn Richard B | Skin formulation |
US4806345C1 (en) * | 1985-11-21 | 2001-02-06 | Johnson & Son Inc C | Cross-linked cationic polymers for use in personal care products |
GB8531118D0 (en) * | 1985-12-18 | 1986-01-29 | Allied Colloids Ltd | Copolymers |
US4704436A (en) * | 1986-05-02 | 1987-11-03 | Barabas Eugene S | Water soluble complex of a poly(vinylpyrrolidone) copolymer and α-methyl-(2-methylpropyl)benzene acetic acid |
US4837019A (en) * | 1986-08-11 | 1989-06-06 | Charles Of The Ritz Group Ltd. | Skin treatment composition and method for treating burned skin |
GB8622797D0 (en) * | 1986-09-22 | 1986-10-29 | Allied Colloids Ltd | Polymeric particles |
US4835206A (en) * | 1986-10-01 | 1989-05-30 | Allied Colloids, Ltd. | Water soluble polymeric compositions |
CH668553A5 (de) * | 1987-02-02 | 1989-01-13 | Mepha Ag | Arzneimittel mit verzoegerter wirkstofffreisetzung. |
US4885161A (en) * | 1987-03-11 | 1989-12-05 | Medi-Tech International Corporation | Wound dressings in gelled paste form |
US4929577A (en) * | 1987-03-11 | 1990-05-29 | Medi-Tech International Corporation | Transparent wound dressings in sheet form |
NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
DE3736970C3 (de) * | 1987-10-30 | 1996-08-01 | Stockhausen Chem Fab Gmbh | Wasserfreie Hautreinigungsmittel und ihre Verwendung |
JPH07116035B2 (ja) * | 1987-12-08 | 1995-12-13 | 塩野義製薬株式会社 | 被膜形成性抗真菌剤組成物 |
JPH0749050B2 (ja) * | 1988-01-18 | 1995-05-31 | 久光製薬株式会社 | 含水ゲル組成物 |
US5182105A (en) * | 1988-10-25 | 1993-01-26 | Kao Corporation | Bathing composition |
GB8909095D0 (en) * | 1989-04-21 | 1989-06-07 | Allied Colloids Ltd | Thickened aqueous compositions |
US5009969A (en) * | 1989-05-26 | 1991-04-23 | Hi-Tek Polymers, Inc. | Dual action sunscreen composition |
JPH0699285B2 (ja) * | 1989-07-07 | 1994-12-07 | 花王株式会社 | 毛髪化粧料 |
GB2236760A (en) * | 1989-10-11 | 1991-04-17 | Inverness Corp | Shaving gel |
US5221530A (en) * | 1991-06-24 | 1993-06-22 | Helene Curtis, Inc. | Mild conditioning shampoo with a high foam level containing an anionic surfactant-cationic acrylate/acrylamide copolymer conditioning agent |
WO1993000882A1 (en) * | 1991-07-08 | 1993-01-21 | R.M. Walker Healthcare Products, Inc. | Neutralizing rinse and improved method for chemically relaxing hair |
EG20380A (en) * | 1991-10-16 | 1999-02-28 | Richardson Vicks Inc | Enhanced skin penetration system for improved topical delivery of drugs |
ES2114569T3 (es) * | 1991-10-16 | 1998-06-01 | Richardson Vicks Inc | Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos. |
CZ90494A3 (en) * | 1991-10-16 | 1994-07-13 | Richardson Vicks | Skin care preparation having the form of aqueous gel |
US5232688A (en) * | 1992-06-17 | 1993-08-03 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Self-tanner cosmetic compositions |
IL140357A0 (en) * | 1998-06-27 | 2002-02-10 | Lci Smartpen Nv | Apparatus and method for end-to-end authentication using biometric data |
-
1993
- 1993-07-12 WO PCT/US1993/006542 patent/WO1994002176A1/en active IP Right Grant
- 1993-07-12 JP JP50451694A patent/JP3567990B2/ja not_active Expired - Lifetime
- 1993-07-12 BR BR9306816A patent/BR9306816A/pt not_active Application Discontinuation
- 1993-07-12 EP EP93917118A patent/EP0652774B1/en not_active Expired - Lifetime
- 1993-07-12 DE DE69310518T patent/DE69310518T2/de not_active Expired - Lifetime
- 1993-07-12 AT AT93917118T patent/ATE152630T1/de not_active IP Right Cessation
- 1993-07-12 KR KR1019950700366A patent/KR950702436A/ko not_active Application Discontinuation
- 1993-07-12 ES ES93917118T patent/ES2101330T3/es not_active Expired - Lifetime
- 1993-07-12 AU AU46739/93A patent/AU4673993A/en not_active Abandoned
- 1993-07-12 CA CA002141192A patent/CA2141192C/en not_active Expired - Lifetime
- 1993-07-27 MX MX9304530A patent/MX9304530A/es unknown
- 1993-07-28 CN CN93116868A patent/CN1072965C/zh not_active Expired - Lifetime
-
1994
- 1994-06-27 US US08/265,975 patent/US5614178A/en not_active Expired - Lifetime
-
1995
- 1995-01-26 NO NO950291A patent/NO950291L/no unknown
- 1995-01-27 FI FI950368A patent/FI950368A/fi not_active Application Discontinuation
-
1998
- 1998-06-16 HK HK98105451A patent/HK1006281A1/xx not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08508024A (ja) * | 1993-03-16 | 1996-08-27 | ロレアル | 非揮発性オルガノポリシロキサンと、ホモポリマータイプまたはアクリルアミドとのコポリマーのタイプのメタクリロイルオキシエチルトリメチルアンモニウムクロライドの架橋ポリマーとを基体とする水性分散液の香粧品中での使用または局所的適用 |
JP2011512377A (ja) * | 2008-02-19 | 2011-04-21 | ユニリーバー・ナームローゼ・ベンノートシヤープ | カチオン性コポリマーとデンプンとを配合したソフトフォーカスな輝きを与える化粧用組成物 |
JP2011512375A (ja) * | 2008-02-19 | 2011-04-21 | ユニリーバー・ナームローゼ・ベンノートシヤープ | カチオン性コポリマーによる光沢および非日光性日焼け色の強化 |
Also Published As
Publication number | Publication date |
---|---|
DE69310518D1 (de) | 1997-06-12 |
AU4673993A (en) | 1994-02-14 |
BR9306816A (pt) | 1998-12-08 |
KR950702436A (ko) | 1995-07-29 |
ES2101330T3 (es) | 1997-07-01 |
MX9304530A (es) | 1995-01-31 |
JP3567990B2 (ja) | 2004-09-22 |
US5614178A (en) | 1997-03-25 |
NO950291D0 (no) | 1995-01-26 |
HK1006281A1 (en) | 1999-02-19 |
DE69310518T2 (de) | 1997-10-02 |
CA2141192A1 (en) | 1994-02-03 |
WO1994002176A1 (en) | 1994-02-03 |
EP0652774A1 (en) | 1995-05-17 |
CN1091317A (zh) | 1994-08-31 |
CA2141192C (en) | 1999-02-02 |
EP0652774B1 (en) | 1997-05-07 |
FI950368A0 (fi) | 1995-01-27 |
NO950291L (no) | 1995-03-27 |
ATE152630T1 (de) | 1997-05-15 |
FI950368A (fi) | 1995-03-10 |
CN1072965C (zh) | 2001-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07509243A (ja) | 架橋陽イオン重合体とアルコキシ化エーテルとを含有する局所用途用医薬組成物 | |
JP3471354B2 (ja) | 薬物の改善された局所送達用の高皮膚浸透系 | |
AU675211B2 (en) | Enhanced skin penetration system for improved topical delivery of drugs | |
EP0189738B1 (en) | Topical compositions for preventing or treating dry skin | |
RU2421216C2 (ru) | Композиции, содержащие по меньшей мере одно производное нафтоевой кислоты и по меньшей мере одно соединение типа полиуретанового полимера или его производное, способы их получения и их применение | |
JPH09510208A (ja) | 酸性活性剤を含有した低pH加水分解安定性化粧品組成物 | |
BRPI0617045A2 (pt) | composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição | |
JP2001517238A (ja) | 特定の液体ポリオール脂肪酸ポリエステル類を含む組成物 | |
EP1219288A2 (en) | Treatment for skin | |
WO1995022351A1 (fr) | Composition pour application locale | |
US20040191206A1 (en) | Methods for reduction of inflammation and erythema | |
JPH09291012A (ja) | 消炎性皮膚化粧料 | |
US7514070B2 (en) | Method for exfoliating skin | |
JPS62413A (ja) | 化粧料 | |
EP0794765B1 (en) | Topical skin care compositions containing nonocclusive liquid polyol carboxylic acid esters as skin conditioning agents | |
JPH09104614A (ja) | 皮膚化粧料 | |
JP2017214343A (ja) | 尋常性ざ瘡治療剤 | |
JPH08165244A (ja) | 皮膚疾患治療剤 | |
JPH0499707A (ja) | 皮膚化粧料 | |
PT100964B (pt) | Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros cationicos especificos | |
MXPA96004033A (en) | Low ph, hydrolically stable cosmetic compositions containing aci assets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040309 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040316 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040426 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040511 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040609 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080625 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090625 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100625 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110625 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110625 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120625 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120625 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term |